7 September 2017 - America’s healthcare debate has stalled in Congress, but constructive dialogue and innovation are thriving in specialised ...
7 September 2017 - We’re at a moment of extraordinary opportunity to improve the public health. New innovations are giving us ...
6 September 2017 - The well-recognised limitations of traditional randomised, controlled trials, including their cost, the nature of the patients and ...
22 August 2017 - Evidence linking interventions with health outcomes is the basis for good health care decision making. ...
23 August 2017 - There is emerging interest in the use of discrete choice experiments as a means of quantifying the ...
7 August 2017 - The appointment of consumer leader, Jo Watson, as the inaugural deputy chairperson of the Pharmaceutical Benefits ...
2 August 2017 - A core principle of good public health practice is to base all policy decisions on the highest-quality ...
23 July 2017 - Health technology assessment is a tool that helps to objectively evaluate evidence, which levels the playing field ...
25 July 2017 - ICER’s fundamental approach to value assessment remains constant with proposed changes for special circumstances. ...
24 July 2017 - NICE is seeking views on a new conflicts of interest policy to ensure its committees’ decisions ...
13 July 2017 - Evidence linking interventions with health outcomes is the basis for good health care decision making. ...
3 July 2017 - The SMC has announced details of the next Scottish Medicines Consortium Industry Engagement Event. ...
2 June 2017 - The appointment of a second consumers representative to the Pharmaceutical Benefits Advisory Committee recognises the value ...
23 May 2017 - Thresholds can be useful to focus the conversation around the value of treatments in healthcare even if ...
1 May 2017 - An overhaul of NHS drug access in England by NICE and NHS England, which for the first ...